Introduction {#sec1_1}
============

Since 1980, worldwide obesity has nearly doubled according to the World Health Organisation (WHO) \[[@B1]\], prompting large amounts of research investigating the aetiology of this condition. Vast amounts of resources are invested each year to target the prevention and treatment of obesity, but results tend to be unsatisfactory, and most people regain any lost weight within 5 years \[[@B2]\]. There is considerable evidence that obesity is driven by an obesogenic environment characterised by an overall abundance of food \[[@B3],[@B4]\] or by a decrease in work-related energy expenditure \[[@B5]\]. However, a recent notion has proposed that obesity may be driven by a person\'s dependence on food in a manner similar to a person\'s dependence on drugs of abuse, potentially stimulating a pathway contributing to sustained overeating and obesity. This concept has been widely termed 'food addiction' (FA), although 'addiction-like eating' and 'eating addiction' have also been used \[[@B6]\].

In 1956, Theron G. Randolph \[[@B7]\] first reported '(...) a common pattern of symptoms descriptively similar to those of other addictive processes' (p. 221) in individuals\' responses to regularly consumed foods. Conditions synonymous with so-called FA have been proposed in scientific literature for many years, particularly the popular labelling of many individuals as 'chocoholics' or 'chocolate addicts'. Such individuals are shown to endorse many criteria associated with addiction, such as tolerance \[[@B8]\] and lack of control \[[@B9]\], and experience intense cravings in response to external chocolate cues \[[@B10]\]. Such research has led to investigators alleging the addictive properties of either sugar (e.g. \[[@B11],[@B12]\]), fat (e.g. \[[@B13]\]) or salt \[[@B14]\]. Similar 'addiction' symptoms in association with sugar-sweetened beverages, particularly Cola, have also been reported \[[@B15]\].

The idea that certain foods and beverages may have addictive potential is not new \[[@B16]\], yet recent developments in research have led to contradictory positions regarding the aetiology of FA. From a biological perspective, the possibility that certain individuals may be genetically or physiologically predisposed to develop an addiction to certain foods has been proposed (e.g. \[[@B17],[@B18]\]). Additionally, researchers (e.g. \[[@B19],[@B20]\]) have claimed that so-called FA may be a neurological condition, consistent with substance dependence and addictive behaviour disorders, as diagnosed by the Diagnostic and Statistical Manual (DSM) \[[@B21]\]. Furthermore, specific foods or ingredients, labelled 'addictive agents' \[[@B13]\], have been suggested to possess the potential to elicit an 'addictive response' in susceptible individuals \[[@B11],[@B14],[@B16]\]. Alternatively, behavioural explanations have implied that FA could be a consequence of a sustained maladaptive pattern of food choice and consumption \[[@B22]\]. Thus, there is uncertainty over whether the existence of FA is a conceivable cause, a co-morbid condition or rather a possible consequence of obesity \[[@B23]\].

The supposition of a condition termed FA -- its definition, aetiology, validity and value -- is not clear, nor fully understood. In addition, the contradictions in the arguments promoting the existence of FA are exacerbated by a lack of balance in the scientific discussion to date. In part, this disparity in the literature can be explained by the development and popularity of a specific questionnaire designed to quantify hypothesised symptoms of FA called the Yale Food Addiction Scale (YFAS). The YFAS is a 25-item self-report instrument, based upon the seven symptomatic criteria for substance dependence as defined by the DSM-IV-TR (table [1](#T1){ref-type="table"}) including two items that assess significant clinical impairment or distress resulting from overeating. A dichotomous diagnosis of FA is applied when at least three criteria and a significant clinical impairment are endorsed. Alternatively, a 'symptom count' can be measured to provide a score between 1 and 7, indicating the severity of the symptomatology. The YFAS was therefore designed to identify or 'diagnose' individuals with addictive eating behaviour patterns and the frequency ('severity') of symptoms endorsed. The scale is widely available, simple to administer and has been shown to demonstrate reliable psychometric properties \[[@B24]\]. Nevertheless, the use of this metric does not validate the construct of FA, but merely assigns to people a score based on their responses to certain questions. The interpretation of these responses is not a simple matter and cannot be automatically assumed to reveal an underlying pathology or psychological condition until such time as the evidence shows otherwise.

Objectives {#sec2_1}
----------

To our knowledge, there have been no systematic research reviews conducted to critically examine both the prevalence and correlates of FA as measured by the YFAS. However, a recent publication by Pursey et al. \[[@B26]\] has estimated the prevalence of FA as defined by the YFAS in 25 studies published before July 2014. Similarly, numerous studies have investigated specific correlates of FA, including measures of psychological distress such as depression \[[@B27]\] and attention deficit hyperactivity disorder (ADHD) \[[@B28]\], pathological eating behaviours such as binge eating disorder (BED) \[[@B29]\] and bulimia nervosa (BN) \[[@B30]\], and weight loss outcomes \[[@B31]\]. However, no review has been conducted to summarise and critically examine these correlates. The present systematic research review therefore provides a critical examination of both the prevalence and correlates of so-called FA, as defined by the YFAS. Specifically, this review aimed to:-- Critically evaluate the prevalence of YFAS-determined FA in multiple groups, including obese and overweight individuals, patients with BED and BN, children and the general population.-- Examine the correlates of YFAS-determined FA, including, but not limited to, psychological distress, weight loss outcomes and susceptibility to maladaptive eating behaviours.-- Evaluate the utility of the YFAS and its application of the DSM-IV-TR criteria for substance dependence in identifying dysfunctional patterns of eating.-- Determine to what extent YFAS-determined FA is successful in identifying a novel behavioural phenotype of overeating, which is diagnostically and behaviourally different to existing eating disorder phenotypes.

Method {#sec1_2}
======

A systematic review of the literature relating to YFAS-determined FA was performed. Titles, abstracts and full texts were screened to assess their eligibility for inclusion using the following search strategy:

Key Terms and Limits {#sec2_2}
--------------------

The literature search was carried out using the key terms 'food addiction', 'food addict\*', 'Yale Food Addiction Scale', 'YFAS' or 'eating addict'. The search results were limited to humans and the English language. As the YFAS was developed in 2009, literature published before this date was not considered.

Databases {#sec2_3}
---------

The search strategy was conducted using the databases Embase, PsycINFO, MEDLINE, Science Direct and Web of Science. Hand searching of citations in review articles provided additional sources.

Inclusion and Exclusion Criteria {#sec2_4}
--------------------------------

No exclusion criteria were applied to sample demographics. Male and female participants of all ages, including children, were included, as were normal-weight, overweight and obese samples. Only experimental studies measuring the prevalence or correlates of YFAS-determined FA were included. As such, all review papers (N = 23), case studies (N = 1), validation studies (N = 7) or non-experimental uses of the YFAS (N = 24) were excluded. Only peer-reviewed articles were included, thus dissertation and thesis papers (N = 3), conference abstracts (N = 22) and books (N = 8) were excluded.

Data Extraction {#sec2_5}
---------------

332 studies were initially identified using the search strategy. A flowchart outlining the data extraction method is presented in figure [1](#F1){ref-type="fig"}. After removing duplicates, 40 relevant studies met the predefined criteria for inclusion in this systematic review. Studies most commonly excluded were those that analysed or reviewed the validity and reliability of the YFAS or similar eating behaviour scales without reporting the prevalence or correlates of FA. Results were summarised according to two main categories: prevalence and correlates. A summary of results is included in supplemental table 1 (available at *[http://content.karger.com/ProdukteDB/produkte.asp?doi=442403](http://www.content.karger.com/ProdukteDB/produkte.asp?doi=442403)*).

19 of the included studies recruited samples of obese or overweight individuals. Of these studies, 12 investigated the associations between YFAS diagnosis and weight loss treatment or surgery, including the prevalence of a YFAS endorsement before and after treatment (N = 4), weight loss outcomes (N = 5), remission of YFAS diagnosis following weight loss surgery (N = 1) and associations between YFAS diagnoses pre-surgery and substance or alcohol misuse post-surgery (N = 3). Two studies recruited individuals with BED. In both of these studies the participants were also overweight or obese, and in one of these investigations the sample was also seeking weight loss treatment. 18 studies investigated the prevalence and correlates of FA in the general population. Ten studies focused on female samples only; however, no studies recruited solely male participants, thus the remaining studies recruited both males and females (N = 30). One study used a sample of children whilst 2 studies recruited samples with eating disorders. The total number of participants across all included studies was 248,474, with sample sizes ranging from 27 to 57,321. 21 studies were published after 2013, whilst only one was published before 2010.

Results {#sec1_3}
=======

Prevalence of Food Addiction {#sec2_6}
----------------------------

36 studies reported the prevalence of YFAS-determined FA in their respective samples. Seven studies reported the YFAS symptom count only, 14 reported the percentage of the sample meeting a dichotomous YFAS diagnosis, and a further 14 reported both. The remaining study did not adhere to the standardised scoring criteria for the YFAS \[[@B32]\]. Of these investigations, 19 reported the prevalence of a YFAS diagnosis in overweight or obese samples, 19 in the general population, 1 in children and 2 in samples with eating disorders, one of which specified BN only and the other included a sample with various ED subtypes. The prevalence of YFAS diagnosis within these clinical and non-clinical populations will be discussed further.

Overweight and Obese Samples {#sec2_7}
----------------------------

The prevalence of reported YFAS diagnoses was consistently greater in overweight and obese samples, relative to normal-weight or underweight individuals. Specifically, the prevalence of a dichotomous YFAS diagnosis in overweight or obese individuals ranged from 15.2% \[[@B33]\] to 56.8% \[[@B29]\] whilst the mean YFAS symptom count reported in these samples ranged from 2.57 \[[@B33]\] to 4.56 \[[@B29]\] out of a possible 7. A comparison of the median prevalence in the overweight or obese samples (33%) and general population (6.8%) reflects a 4 to 5 times greater YFAS prevalence in overweight and obese samples. This value exceeds previous findings by Avena et al. \[[@B34]\], who reported a two- to threefold increase in YFAS diagnosis in obese individuals compared to normal-weight samples, and the results of a meta-analysis by Pursey et al. \[[@B26]\], who reported that the prevalence of FA was doubled in the overweight/obese population compared with healthy weight individuals. The highest prevalence rates were reported in overweight and obese patients seeking weight loss surgery, in whom prevalence rates reached 53.7% \[[@B35]\].

Binge Eating Disorder and Bulimia Nervosa {#sec2_8}
-----------------------------------------

Across all relevant studies, participants who met the YFAS diagnosis were significantly more likely to also fulfil BED criteria, supporting similar findings by Davis et al. \[[@B28]\]. The highest prevalence amongst individuals with BED was reported by Gearhardt et al. \[[@B29]\] and reached 56.8%, whilst the highest mean YFAS symptom count of 4.56 in a sample with BED was reported in the same study.

The prevalence of a YFAS diagnosis was found to be greater still in patients with BN. For example, Gearhardt et al. \[[@B36]\] reported the prevalence in BN patients to reach 83.6%, compared to 47.2% in individuals with BED. Additionally, in a study conducted by Meule et al. \[[@B30]\], all 26 patients with current BN scored sufficiently to qualify for YFAS diagnosis, compared with only 30% of remitted BN participants and none of the healthy control group.

Adult General Population {#sec2_9}
------------------------

In the 19 studies that reported the prevalence of YFAS-diagnosed FA in the general population, the prevalence ranged from 0% \[[@B30]\] to 8.7% \[[@B37]\] whilst the mean YFAS symptom count ranged from 0.86 \[[@B30]\] to 3.05 \[[@B36]\].

Children {#sec2_10}
--------

Only one study reported the prevalence of a YFAS diagnosis in children \[[@B38]\]. In this sample of 75 children, 7.2% met the YFAS diagnostic criteria. This study utilised the adapted version of the YFAS for children (YFAS-C), adapted from the original YFAS by referring to age-appropriate activities and adapting the questions to a lower reading grade. The YFAS-C was reviewed for clarity by a panel with expertise in addiction and childhood obesity and includes 25 questions that relate to the same diagnostic criteria as the original YFAS.

Additionally, in two retrospective studies \[[@B39],[@B41]\], a positive association was found between the likelihood of endorsing a YFAS diagnosis and experiencing physical abuse, sexual abuse or post-traumatic stress disorder (PTSD) in childhood or adolescence. Furthermore, Davis et al. \[[@B28]\] reported a significant association between current YFAS diagnosis and those retrospectively meeting the criteria of a probable diagnosis of childhood ADHD.

Correlates of Food Addiction {#sec2_11}
----------------------------

Across all reviewed studies, a range of psychometric and demographic measures were assessed and their relationships with YFAS diagnoses were considered and quantified. The most commonly implicated outcome measures will be discussed further.

BMI {#sec2_12}
---

The majority of studies measured BMI within the sample, but not all reported the relationship between the YFAS and BMI. In studies recruiting participants with a range of BMIs (N = 18), YFAS diagnosis was found to be positively correlated with a higher current BMI \[[@B40]\] and a greater maximum reported adult BMI \[[@B36]\]. Specifically, Mason et al. \[[@B39]\] reported that female nurses meeting YFAS diagnostic criteria were 6 BMI units (kg/m^2^) heavier than those who did not meet the criteria, supporting the conclusions of Flint et al. \[[@B41]\] that those meeting a YFAS diagnosis are more likely to be overweight. In addition to this, Pedram et al. \[[@B42]\] reported that when individuals endorsing the YFAS criteria were classified according to their BMI, 11.4% of the so-called food addicts were under- or normal-weight whilst 88.6% were overweight/obese. A relationship between YFAS diagnosis and BMI was also found in children, whereby elevated scores on the YFAS-C were significantly positively correlated with higher BMI.

Conversely however, no difference in BMI between YFAS-diagnosed 'food addicts' and 'non-food addicts' was reported by Meule and Kubler \[[@B43]\] in a sample with a wide range of BMIs. A similar finding was reported in a sample where BMI fell within a healthy range \[[@B44]\]. Similarly, Gearhardt et al. \[[@B19]\] and Eichen et al. \[[@B33]\] found no correlation between BMI and YFAS scores; however, subjects who reported binge eating or compensatory behaviours were excluded from the sample. Additionally, Burgess et al. \[[@B45]\] reported that YFAS scores did predict some of the variance in BMI in their college student sample, but this association disappeared after binge eating scores were controlled for. Competing interpretations of this finding support either a moderating role for binge eating in the association between YFAS-diagnosed FA and BMI or that YFAS items may be confounded with binge eating scores and explain no additional variance.

Binge Eating Behaviour {#sec2_13}
----------------------

17 studies measured binge eating behaviour in overweight or obese samples (N = 11), the general or healthy population (N = 5) and patients with eating disorders (N = 2). Results were consistent across studies, demonstrating that those meeting a YFAS diagnosis were more likely to report binge eating behaviour (e.g. \[[@B35],[@B36]\]) or meet criteria for a BED diagnosis (e.g. \[[@B28],[@B37]\]). For example, among subjects who met the YFAS diagnosis, 28.9% also endorsed clinical criteria for BED, compared with 4.1% of those who did not fulfil YFAS criteria \[[@B46]\].

Specifically, so-called food addicts reported more frequent binge eating episodes whereby number of binges per week was found to be correlated with YFAS scores \[[@B29],[@B40],[@B47]\]. YFAS symptom count was a significant correlate of frequency of binge eating episodes, even after controlling for troubled and emotional eating \[[@B24]\]. A dichotomous YFAS diagnosis was also identified as a significant predictor of the frequency of binge episodes in overweight or obese BED patients \[[@B29]\]. Furthermore, contrary to Boggiano et al. \[[@B48]\], YFAS score accounted for 11.1% of unique variance in binge eating episodes after controlling for the variance accounted for by depressive mood and eating disorder psychopathology \[[@B49]\]. In addition to this, YFAS symptom count correlated significantly with binge eating scores in both overweight patients and healthy weight controls \[[@B48]\]. This suggests that the relationship between binge eating and so-called FA can be found irrespective of weight status.

Psychological Wellbeing {#sec2_14}
-----------------------

Given the compromised psychological wellbeing commonly associated with substance addictions, for FA to warrant classification as an addiction it should be assumed that a clinical level of psychological impairment should exist. As such, 27 of the included studies have investigated associations between YFAS diagnoses and various markers of psychological wellbeing. These include depression (N = 10), general psychopathology (N = 2), substance (N = 6) and alcohol abuse (N = 6), ADHD (N = 1), PTSD (N = 1) and physical or sexual abuse in childhood or adolescence (N = 1).

The relationship between YFAS diagnoses and depression has generated mixed results. Several studies have reported a positive association of both a dichotomous YFAS diagnosis \[[@B30],[@B33],[@B41],[@B50]\] and YFAS symptom count \[[@B27],[@B51]\] with depression, whilst self-reported 'food addicts' have been reported to have a significantly higher prevalence of severe depression compared with 'non-food addicts' \[[@B28]\]. Such effects have persisted even in studies where subjects with major depressive disorder were excluded \[[@B33]\]. However, this association has not been replicated across the board, with some studies failing to report an association between YFAS diagnosis and mood disorders, negative affect as well as emotion dysregulation \[[@B49]\]. In a study by Imperatori et al. \[[@B46]\] on overweight and obese patients seeking weight loss therapy, it was reported that the relationship between YFAS diagnosis and psychopathology was fully accounted for by binge eating severity, therefore raising the likelihood of redundancy between binge eating scores and YFAS scores.

Researchers have investigated the relationship between so-called FA and clinically defined substance use disorders, such as alcohol and drug dependence. Again, findings have been mixed, with some researchers reporting an association between YFAS diagnosis and problematic substance use \[[@B35]\] and alcohol use \[[@B24]\]. However, in 2 samples of overweight or obese adults, no correlation between YFAS diagnosis and alcohol or drug use was reported \[[@B29],[@B49]\], whilst Meule et al. \[[@B50]\] found that subjects endorsing YFAS criteria had lower scores on the Alcohol Use Disorder Identification Test (AUDIT).

In a sample of 141 adults post weight loss surgery, those meeting a pre-surgical YFAS diagnosis were more likely to report problematic substance use post-surgery \[[@B52]\]. Furthermore, those participants meeting a post-surgery problematic substance use were found to lose less weight. The authors argued that YFAS assessment of FA pre-surgery could help to prevent post-surgery substance use, a process consistent with 'addiction transfer' \[[@B52]\].

In the studies reporting ADHD, PTSD and sexual or physical abuse in childhood or adolescence \[[@B28],[@B39],[@B53]\], such disturbances were all found to be risk factors for so-called FA in adulthood. The likelihood of a YFAS diagnosis was further amplified if the abuse or trauma began at a younger age or lasted longer, suggesting a potential antecedence of psychological disturbance in childhood or adolescence in the presence of so-called FA in later life.

Weight Loss Outcomes {#sec2_15}
--------------------

12 studies were reviewed that focused on the relationship between YFAS diagnostic criteria and weight loss. Of these, the majority (N = 9) recorded patients seeking weight loss treatment or bariatric surgery, whilst 1 reported patients currently undergoing treatment and 2 measured samples post treatment. Findings in this area were mixed. For example, Lent et al. \[[@B54]\] reported that, after controlling for treatment type, baseline weight and sex, YFAS symptom count did not significantly contribute to the variance in weight change following treatment. Furthermore, the presence of a dichotomous YFAS diagnosis at the start of the weight loss intervention study did not reduce subsequent weight loss, with patients who met YFAS criteria losing comparable amounts of weight as those who did not.

Interestingly, surgery-induced weight loss was reported to induce a remission in YFAS diagnoses in 93% of obese/overweight so-called food addicts \[[@B31]\]. In contrast however, Burmeister et al. \[[@B27]\] reported that those individuals with a YFAS diagnosis showed a reduced weight loss after a 7-week intervention. A similar but non-significant effect was also found by Clark and Saules \[[@B35]\]. These results outline the uncertainty of the status of FA in the treatment of obesity and cannot conclusively determine whether a YFAS diagnosis provides any useful information in a weight loss setting.

Discussion {#sec1_4}
==========

The present systematic research review aimed to critically examine the existing literature investigating the prevalence and correlates of so-called FA in order to increase understanding of its current status as a hypothesised condition. The specific aims of this review are discussed below along with some critical issues encountered.

Prevalence and Correlates of Food Addiction {#sec2_16}
-------------------------------------------

The prevalence of so-called FA, as diagnosed by the YFAS, has been reported in numerous populations. The highest prevalence rates of YFAS diagnoses were found in samples of overweight or obese individuals. However, contrary to some researchers\' assumptions, the increased prevalence of a YFAS diagnosis in these samples does not validate the existence of FA as a novel behavioural phenotype which explains over-consumption. The high prevalence of YFAS-determined FA in obese and overweight samples has been suggested to provide evidence that so-called FA is contributing to the rising obesity epidemic in the general population. However, it is premature to suggest that this construct plays a causal role in the development of obesity, especially given that the vast majority of studies reviewed relied on cross-sectional designs, a point which is also acknowledged by Pursey et al. \[[@B26]\] as clouding 'interpretation of cause and effect among variables' (p. 4582). The label of FA may become attached to people destined to become obese due to a positive energy balance arising from multiple features of the obesogenic environment.

Similarly, high YFAS prevalence rates were identified in samples who engaged in binge eating behaviour. This has prompted authors to propose that so-called FA may be an atypical subtype of BED. However, the prevalence of YFAS diagnoses in obese samples with BED generally failed to reach 50% (e.g. \[[@B49]\]), suggesting either that a YFAS diagnosis is not synonymous with BED or obesity and therefore warrants consideration as a unique condition, or equally that the YFAS does not capture the full spectrum of heterogeneity that characterises the experience of individuals with BED or obesity. The question of whether a label of FA contributes any unique variance to a diagnosis of binge eating is an important issue that needs to be clarified.

It has been argued that so-called FA may be an extreme subtype of BED. Support for this idea comes from research by Davis et al. \[[@B55]\] who reported that a dopaminergic genetic profile could differentiate between those obese individuals who received a YFAS diagnosis and those who did not. This notion is further supported by Imperatori et al. \[[@B46]\] who noted that, although the prevalence of a YFAS diagnosis in obese samples with BED was very high, the prevalence was lower when studying obese populations without BED. The authors concluded that an atypical binge eating phenotype might exist in a small subgroup of obese individuals who also manifest other symptoms that are best captured by the YFAS compared to the Binge Eating Scale. However, even the most conservative prevalence estimates are still much higher than would be expected if so-called FA were simply a subtype of BED. Whether this suggests that FA may in fact be a less extreme subtype, reflecting a greater overlap and encompassing more of the behavioural phenotype associated with BED, or conversely that it is in fact distinct from BED to a greater extent than primarily suggested, is yet to be conclusively determined. To suggest that an obese individual who meets a YFAS diagnosis is at greater risk than a BED patient who does not meet a YFAS diagnosis therefore remains unsubstantiated.

One possibility proposed to explain the interrelationship between YFAS diagnosis, obesity status and binge eating is that binge eating could mediate the relationship between YFAS diagnosis and increasing BMI \[[@B45],[@B46]\]. However, these mediation effects could also be attributed to the idea that the characteristics displayed by 'addicted' individuals may already be accounted for by scientifically validated binge eating diagnoses and definitions \[[@B30]\]. Longitudinal studies are required to disentangle these associations.

Despite this possibility, attempts to draw parallels between substance dependence and binge eating are restricted due to the differences in core psychopathology between these disorders. As suggested by Meule et al. \[[@B30]\], in BED and other eating disorders concerns regarding body weight and shape often drive dysfunctional eating patterns which, in turn, lead to binge eating episodes and possible compensatory behaviours. Such aspects are absent in other addictive behaviours like compulsive drug taking, rendering similarities between drug dependence and so-called FA tentative. Even when investigations are restricted to BED samples, many characteristics that are essential for diagnosis of substance dependence are not fully applicable to eating behaviours. For example, tolerance and withdrawal are particularly difficult to discern from processes of hunger and satiety when related to eating behaviour \[[@B33],[@B56],[@B57]\], This idea is supported by Ziauddeen and Fletcher \[[@B56]\] who concluded that the inconsistent nature of reported similarities between obesity, binge eating and so-called FA reflects the limited applicability of the 'FA hypothesis' which may be better represented by binge eating.

This idea can be extended to explain the high prevalence of YFAS diagnoses in patients with BN. Such a prevalence could be attributed simply to the overlapping symptoms between this condition and BED \[[@B48]\]. Few data are available with only 3 studies investigating the prevalence of YFAS diagnosis in BN patients. Interestingly, BN has been described as an extreme form of BED \[[@B58]\] with additional compensatory behaviours (such as purging, laxative use and excessive exercise). This might explain the increased prevalence of YFAS diagnoses seen in BN patients but also calls into question whether so-called FA in and of itself has a role as a biological cause of overeating.

Problems in Defining Food Addiction {#sec2_17}
-----------------------------------

Attempts to evaluate the literature on so-called FA are hindered by the lack of formal definition for this condition \[[@B23],[@B34],[@B59]\]. Few instruments other than the YFAS have been utilised to identify addictive eating behaviour \[[@B60]\]. For example, the Eating Behaviours Questionnaire (EBQ) developed for paediatric samples, consists of 20 hypothesised symptoms of FA based on adaptations of DSM-IV criteria for substance dependence \[[@B61]\]. Whilst Goodman\'s \[[@B62]\] broadened diagnostic criteria for addictive disorders have also been assessed in women with BED \[[@B63]\], the authors concluded that the classification of BED should remain an eating disorder. However, the most commonly used tool to quantify so-called FA symptomatology is the YFAS itself \[[@B24]\]. This poses problems in disentangling the existence of so-called FA as a clinical entity from the psychometric measurement of FA provided by the YFAS. The assessment of so-called FA using the YFAS has fuelled support for its existence as a valid clinical condition \[[@B23]\], despite diagnoses being based on self-report responses, frequently in individuals who are motivated to assign responsibility for their problematic eating behaviour to factors beyond their control, a point that was also raised in the meta-analysis by Pursey et al. \[[@B26]\].

Applying the term 'addiction' to food is further impeded as the semantics of this label are fluid and may no longer be appropriate. For example, drug-related conditions are no longer labelled addictions but 'substance-related disorders'. It therefore seems unhelpful to persist with the term FA, especially as its supposed diagnosis arises from a questionnaire based on the criteria for substance dependence. There is a risk that the term 'FA' could be used by some investigators for dramatic effect or to make the diagnosis appear toxic.

Whilst YFAS-diagnosed FA does seem to identify individuals with certain maladaptive eating behaviours \[[@B19],[@B24],[@B33],[@B39]\], problems are inherent in the direct application of the DSM-IV-TR criteria for substance dependence as the basis of a psychometric tool for so-called FA. The diagnostic labels in the DSM are intended for trained and experienced clinicians rather than a checklist for self-diagnosis. Indeed, the diagnosis of any other scientifically validated addictive or eating disorder would not rely on a self-report questionnaire as justification for diagnosis. Furthermore, defining so-called FA under the same criteria as substance dependence and addictive behaviour is controversial because, unlike drugs or gambling, food and eating are essential for survival. There is disagreement over the equivalence of symptoms of substance use disorders and the appropriateness of their application to so-called FA \[[@B23],[@B30]\], especially given the abundance of foods in the diet that contain high proportions of the various candidate 'addictive agents' (e.g. fats, sugars and salt).

One feature of the YFAS is the inclusion of two items designed to indicate 'clinical impairment', which must both be met in order to warrant an affliction on a similar level as would be expected in a drug-addicted individual. However, few studies have actually investigated the level of clinical impairment experienced by individuals who meet the YFAS diagnosis \[[@B28]\]. Instead, researchers tend to favour the YFAS symptom count score as it yields more power to detect relationships in small samples \[[@B27]\], despite there being a lack of evidence to support this continuum \[[@B56]\]. However, the use of the YFAS score or symptom count does not in itself imply an identification of FA. The use of a single instrument (the YFAS) to identify FA introduces the possibility of a circular argument. To the question 'Why is this person a food addict?', the answer is 'Because of a high score on the YFAS'. But the answer to the question 'Why does this person score high on the YFAS?', the answer is 'Because he/she is a food addict'. The circularity of this deduction can only be broken by the assignation of separate clinical symptoms of FA that are independent of the YFAS score.

Whilst there is a plausible rationale for adopting an addiction model in understanding the spectrum of overeating across individuals \[[@B23]\], for this concept to progress into a distinct clinical entity will require scientific development and understanding beyond those existing clinical diagnoses of eating disorders and definitions of addiction, and into a coherent model of FA, encompassing and identifying the precise psychological impairments specific to those endorsing the spectrum of traits associated with the condition.

The methodologies adopted to examine the context of so-called FA are to date limited. Only three studies \[[@B19],[@B42],[@B64]\] analysed the YFAS and its relationship with actual food choice or intake. This weakens the argument suggesting that certain foods or food groups may be addictive (e.g. \[[@B11],[@B13]\]) as the behavioural evidence in human populations to support such claims is not yet established. Furthermore, several authors have adopted language in their studies that appears to confirm the existence of so-called FA, such as 'hyper-palatable' and 'addictive response'. Just like the term 'FA' itself, these terms do not have a clear definition and can be used to layer a biased interpretation on top of otherwise neutral data.

As mentioned previously, a further limitation of the YFAS is its design based on the now outdated DSM-IV symptom criteria. In 2013, the 5th edition of the DSM was published, reflecting major changes made to the previously titled 'Substance-Related Disorders' chapter \[[@B21]\]. This category was re-named to 'Substance-Related and Addictive Disorders' and further subdivided into 'Substance-Related Disorders' and 'Non-Substance-Related Disorders' \[[@B65]\]. Despite some postulations (e.g. \[[@B13],[@B66],[@B67]\]), no specific food or ingredient has yet to be conclusively characterised as an addictive agent in humans, furthermore gambling disorder was the sole behavioural condition acknowledged under the non-substance-related disorders category. One explanation for the lack of recognition of FA under the DSM-V can be attributed to the idea that the term generates confusion and conflicting accounts as it straddles both substance-related and non-substance-related disorders \[[@B17]\]. There are researchers who strongly implicate certain foods, such as highly processed foods \[[@B13]\], which they argue may be more likely to trigger an addiction in susceptible individuals via similar mechanisms as drugs of abuse \[[@B19]\]. However, contrasting views have suggested that simply the behaviour of eating is potentially addictive \[[@B17],[@B68]\], triggering debate over whether overeating, to the extent where it reflects an addiction, is best conceptualised as a maladaptive pattern of behaviour or as a substance-related disorder. In response to this, the term 'eating addiction' \[[@B6]\] has been proposed to acknowledge addiction to eating on a behavioural level, although this label is yet to be debated in the literature. Moreover the term 'eating addiction' retains the semantically charged term 'addiction' rather than a more neutral term which might be better suited to the provisional recognition of the condition.

In light of the DSM-V, only two symptoms now need to be met in order for an individual to be given a diagnosis of substance dependence, compared to three symptoms in the DSM-IV. If such criteria are adapted for the psychometric assessment of so-called FA, it is likely that the current prevalence estimates for the diagnosis of FA will no longer apply due to lower diagnostic thresholds \[[@B68]\]. Future research that utilises the DSM-V should therefore attempt to extricate the diagnostic criteria for FA from the existing classification for substance use disorders in order to avoid over-diagnosis and misleading prevalence estimates.

Problems in Identifying Addictive Foods {#sec2_18}
---------------------------------------

Many researchers are turning their attention to identifying specific foods or ingredients that may have the ability to trigger a so-called addictive response in susceptible individuals. Such 'addictive agents' \[[@B13]\] include ingredients that are added to enhance the palatability of foods, without necessarily increasing the nutritional value. Refined carbohydrates, fat and salt, often in combination, are commonly identified in highly processed foods and are frequently associated with excessive consumption \[[@B69]\]. It is unsurprising, therefore, that patients with BED often identify foods high in these ingredients as triggering binge episodes \[[@B28]\]. Furthermore, the foods listed on the YFAS, which individuals commonly identify as having difficulty controlling, are mostly highly processed foods, such as chips, pizza, pastries, savoury snacks and soda pop \[[@B24]\].

However, the extrapolation of these limited reports to support the idea that highly processed foods can trigger an addiction is as yet unwarranted, given that the majority of these outputs rely on a very small number of studies conducted in animal models. Whilst rodents can display behavioural phenomena resembling addiction symptomatology, such as withdrawal from high-fat foods (whereby behavioural anxiety and depression are displayed) \[[@B70]\] and persistent seeking of sugar via lever pressing \[[@B11]\], behavioural evidence of these effects has not been replicated in humans \[[@B56]\]. At this stage, the most scientifically secure conclusion is that the availability and consumption of palatable foods has the potential to alter behaviour and activate the neural circuitry implicated in food reward. Whether these activations have the power to develop a dependence on such foods in the same way as would be expected with drugs of abuse is yet to be established. This is particularly difficult to achieve as, unlike drugs, foods are consumed ubiquitously and are necessary for survival \[[@B56]\].

Usefulness of the Term 'Food Addiction' {#sec2_19}
---------------------------------------

One issue still to resolve is the extent to which so-called FA is a novel label for susceptibility to already known forms of overeating \[[@B22]\]. This behaviour is well documented and defined by clinically recognised conditions such as BED \[[@B63]\]. Vainik et al. \[[@B71]\] suggested that many common eating-related traits can all be captured by a single factor, labelled 'uncontrolled eating' (p. 229), presented on a continuum indicating severity. This continuum model is in line with that proposed by Davis \[[@B22]\] and further highlights the overlaps between the hypothesised classification of FA and existing maladaptive eating behaviour phenotypes. However, such a continuum does not justify the acceptance of so-called FA as a distinct clinical entity. At the present time, the concept of so-called FA at the individual level as a putative biological cause of overeating is controversial and lacks convincing support. The term is also not widely regarded as helpful by clinicians in advancing scientific understanding of eating disorders or as an explanation for obesity.

Conclusion {#sec1_5}
==========

This systematic review of 40 studies is the largest to date and has uncovered mixed results regarding the prevalence and correlates of so-called FA. Notably, YFAS scores were higher in overweight or obese samples or those with BED, prompting researchers to conclude that FA may be a subtype of BED, reflecting many of the problematic eating behaviours endorsed by those who have been unsuccessful in controlling their weight. However, the existence of a growing body of uncritical scientific literature, which makes the assumption that so-called FA is a true condition, may hinder progress in identifying preventable causes of overeating. The designation of any new putative mental disorder should not be taken lightly but should contribute novel information to the field which assists in explaining or treating pathology and should not overlap extensively with existing validated explanations and disorders. As a counter to this, a body of objective scientific research is required to investigate the utility of the concept of FA in the current scientific literature before it is accepted by the scientific population and communicated to the public, for example, by objectively measuring energy intake (EI) and macronutrient choice following a dietary manipulation and comparing EI in 'food addicted' versus healthy individuals. At the present time there is a need for well-funded large-scale scientifically controlled trials preferably carried out by un-biased researchers. At this stage, and consistent with scientific practice, the existence of so-called FA and its relationship with other psychological processes should be regarded as inconclusive until such time as the evidence base becomes stronger.
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###### 

The DSM-IV-TR criteria for substance dependence \[[@B25]\]

  --------------------------------------------------------------------------------------------------------------------------------------
  1\) Substance taken in larger amount and for longer period than intended
  2\) Persistent desire or repeated unsuccessful attempts to quit
  3\) Much time/activity to obtain, use, recover
  4\) Important social, occupational, or recreational activities given up or reduced
  5\) Use continues despite knowledge of adverse consequences (e.g., failure to fulfil role obligation, use when physically hazardous)
  6\) Tolerance (marked increase in amount; marked decrease in effect)
  7\) Characteristic withdrawal symptoms; substance taken to relieve withdrawal
  8\) Use causes clinically significant impairment or distress
  --------------------------------------------------------------------------------------------------------------------------------------
